 |
 |
 |
|
Cerebrin helps clear damp heat toxins in the brain. It helps clear brain infections caused by low virulence gram-negative bacteria that is accessible through small brain blood vessels. Brainin-2 is recommended in combination with the treatment to clear mycobacterial infections in the brain.
1. Brain Gram-negative Bacterial Infections
The infection can cause irritation to the microglia cell and neurons affecting brain functions. Patients may experience leg muscle spasm, dizziness, headache and sleepiness. Over time, the infection can cause damage to the brain and scar tissue formation resulting in either physiological or psychiatric problems. Cerebrin helps clear gram negative bacteria in the brain that is accessible through small brain blood vessels. Treatment with Resurgen and Surgenin before and while using Cerebrin is recommended to help reduce inflammation and remove blockage of the small brain blood vessels. Patients should experience symptom improvement in 3 days. 3-4 weeks of treatment is required to have significant improvement and sustained results. Patients who have gram negative bacterial infections usually have coinfections with mycobacteria and/or spirochete. Brainin-2 is also required to clear mycobacteria and Spiromin-R is required to clear spirochete that are accessible through small brain blood vessels. If there is scar formation, Gold is also required to dissolve the scar in the brain while using the Brainin-2, Cerebrin and Spiromin-R. If there is inflammation in the brain, Platinum is also required.
Suggested Dosage: 2 capsules, 3 times a day
Ingredients: Bulbus Lilii, Flos Albiziae, Fossilia ossis mastoid, Plumula Nelumbinis, Radix Ophiopogonis, Radix Ourcumae, Radix Pseudostellariae, Radix Puerariae, Radix Rehmanniae, Radix Salviae Miltiorrhizae, Rhizoma Anemarrhenae, Rhizoma Polygonati Odorati, Semen Ziziphi Spinosae, Thinleaf Milkwort Root
Pinyin Name: Taizishen, Maidong, Yuzhu, Danshen, Yujin, Yuanzhi, Gegen, Lianzixin, Zhimu, Dihuang, Baihe, Longgu, Hehuanhua, Suanzaoren
|
|
|
 |
|
 |
|
